Markets
← Back to Stocks
CI
THE CIGNA GROUP
Health Care · Health Care Services
$264.60
-0.28%
Vol: 0.0M
Araverus Market Read
Thursday, March 19, 2026
CEO succession plan and Bernstein upgrade to Outperform offset pre-market weakness.
Cigna Group announced Brian Evanko will succeed David M. Cordani as CEO by July 2026, with Bernstein upgrading the stock to Outperform and setting a $358 price target, signaling confidence in leadership transition execution. Pre-market trading shows weakness at $282.78 (down 2.77%), indicating investors may be cautious about management change timing, but Bernstein's upgrade and $358 PT suggest long-term upside. The ongoing focus on pharmacy benefit manager reforms adds complexity but also potential for operational improvements.
Price 50d 200d
Previous Market Reads
2 of 2 days↑
Sector Peers
| Company | Price | Day | 1M | Fwd P/E | Beta | Mkt Cap |
|---|---|---|---|---|---|---|
| LLYELI | $916.83 | -0.13% | -11.4% | 21.8x | 0.43 | $821.2B |
| JNJJOHNSON | $237.56 | +0.16% | -1.8% | 18.9x | 0.33 | $572.6B |
| ABBVABBVIE | $206.31 | -0.97% | -11.4% | 12.8x | 0.33 | $364.6B |
| MRKMERCK | $114.17 | -0.29% | -5.4% | 11.7x | 0.26 | $282.3B |
| UNHUNITEDHEALTH | $280.37 | -1.29% | -2.2% | 14.1x | 0.38 | $254.5B |
| AMGNAMGEN | $349.90 | -0.42% | -6.3% | 15.0x | 0.42 | $188.6B |
| ABTABBOTT | $107.19 | -1.12% | -4.5% | 17.2x | 0.74 | $186.3B |
| GILDGILEAD | $141.06 | -0.17% | -8.6% | 14.7x | 0.37 | $175.2B |
| TMOTHERMO | $470.21 | +1.18% | -6.2% | 17.5x | 0.97 | $174.7B |
Fundamentals
Market Cap$70.7B
P/E (TTM)11.9
Forward P/E7.9
Beta0.23
Div Yield236.00%
Prev Close$265.35
RSI (14-Day)
24Oversold
0305070100
52-Week Range
$239.51$264.60$350.00
From High-24.4%
From Low+10.5%
Moving Averages
50d SMA
$277.01-4.5%
200d SMA
$285.19-7.2%
Price below 200d MA — bearish structure.
Returns
1W
-0.5%
1M
-8.3%
3M
-3.6%
6M
-9.8%
1Y
-16.2%
YTD
-4.7%
Volume
Today28K
20d Avg1.8M
Ratio0.02x